Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hall

Showing results (831-840 of 1,784) with videos related to

Pageof 179
Sort By:
European Journal of Cancer Care|July 9, 2002
Evaluation of a patient-held record for patients with cancerJ Lecouturier, L Crack, K Mannix, et al.
Lipids|July 1, 1990
Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodentsJ M Chapman, P DeLucy, O T Wong, et al.
Spine|February 24, 2000
Prognostic factors for time receiving workers' compensation benefits in a cohort of patients with low back painG McIntosh, J Frank, S Hogg-Johnson, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodentsR Simlot, R A Izydore, O T Wong, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1988
Follicle-stimulating hormone induces transient expression of the protooncogene c-fos in primary Sertoli cell culturesS H Hall, D R Joseph, F S French, et al.
Metal-Based Drugs|May 14, 2008
The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male MiceM C Miller, A Sood, B F Spielvogel, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1988
The gene structure of rat androgen-binding protein: identification of potential regulatory deoxyribonucleic acid elements of a follicle-stimulating hormone-regulated proteinD R Joseph, S H Hall, M Conti, et al.
Current Drug Discovery Technologies|February 14, 2006
QSAR modeling of carcinogenic risk using discriminant analysis and topological molecular descriptorsJoseph F Contrera, Philip Maclaughlin, Lowell H Hall, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1979
Prediction of peak penicillin and cephalosporin concentrations in canine serum as derived from in vitro serum and tissue quantitative protein bindingL R Peterson, D N Gerding, D McLinn, et al.
Journal of Medicinal Chemistry|February 1, 1974
Cycloalkanones. 3. Structure-activity relationships of hypocholesterolemic cyclooctanone derivativesG L Carlson, I H Hall, G S Abernethy, et al.
Pageof 179

Showing results (831-840 of 1,784) with videos related to

Sort By:
Pageof 179
European Journal of Cancer Care|July 9, 2002
Evaluation of a patient-held record for patients with cancerJ Lecouturier, L Crack, K Mannix, et al.
Lipids|July 1, 1990
Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodentsJ M Chapman, P DeLucy, O T Wong, et al.
Spine|February 24, 2000
Prognostic factors for time receiving workers' compensation benefits in a cohort of patients with low back painG McIntosh, J Frank, S Hogg-Johnson, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodentsR Simlot, R A Izydore, O T Wong, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1988
Follicle-stimulating hormone induces transient expression of the protooncogene c-fos in primary Sertoli cell culturesS H Hall, D R Joseph, F S French, et al.
Metal-Based Drugs|May 14, 2008
The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male MiceM C Miller, A Sood, B F Spielvogel, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1988
The gene structure of rat androgen-binding protein: identification of potential regulatory deoxyribonucleic acid elements of a follicle-stimulating hormone-regulated proteinD R Joseph, S H Hall, M Conti, et al.
Current Drug Discovery Technologies|February 14, 2006
QSAR modeling of carcinogenic risk using discriminant analysis and topological molecular descriptorsJoseph F Contrera, Philip Maclaughlin, Lowell H Hall, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1979
Prediction of peak penicillin and cephalosporin concentrations in canine serum as derived from in vitro serum and tissue quantitative protein bindingL R Peterson, D N Gerding, D McLinn, et al.
Journal of Medicinal Chemistry|February 1, 1974
Cycloalkanones. 3. Structure-activity relationships of hypocholesterolemic cyclooctanone derivativesG L Carlson, I H Hall, G S Abernethy, et al.
Pageof 179